SUMMARY
In response to many apoptotic stimuli, oligomerization of Bax is essential for mitochondrial outer membrane permeabilization and the ensuing release of cytochrome c. These events are accompanied by mitochondrial fission that appears to require Drp1, a large GTPase of the dynamin superfamily. Loss of Drp1 leads to decreased cytochrome c release by a mechanism that is poorly understood. Here we show that Drp1 stimulates tBid-induced Bax oligomerization and cytochrome c release by promoting tethering and hemifusion of membranes in vitro. This function of Drp1 is independent of its GTPase activity and relies on arginine 247 and the presence of cardiolipin in membranes. In cells, overexpression of Drp1 R247A/E delays Bax oligomerization and cell death. Our findings uncover a function of Drp1 and provide insight into the mechanism of Bax oligomerization.
INTRODUCTION
In mammalian cells undergoing apoptosis, many proteins that are confined to the intermembrane space of mitochondria are released as a result of the mitochondrial outer membrane (MOM) becoming permeable. Permeabilization of the MOM is ensured by proapoptotic members of the Bcl-2 family such as Bax or Bak (Kroemer et al., 2007; Schinzel et al., 2004) . Whereas Bak is an integral MOM protein, Bax is inactive in the cytosol and soluble, or loosely attached to mitochondria, until it is activated by a diverse array of apoptotic stimuli (Youle and Strasser, 2008) . Bax then undergoes conformational changes, translocates, and inserts into the MOM and oligomerizes, inducing MOM permeabilization (MOMP). These conformational rearrangements occur in the MOM and require a tight cooperation between Bax or Bak, BH3-only proteins, and the lipid bilayer (Lucken-Ardjomande and Martinou, 2005) . The current model postulates that tBid serves as a receptor for Bax, allowing its insertion and oligomerization in the membrane (Lovell et al., 2008) . Other BH3-only proteins such as Bim, MAP-1, or Puma could also directly bind and recruit Bax in the MOM as does tBid (Certo et al., 2006; Gallenne et al., 2009; Gavathiotis et al., 2008; Marani et al., 2002; Tan et al., 2005; Walensky et al., 2006) . Moreover, components of the TOM complex and Endophilin B1/Bif-1 appear to be important to fine-tune Bax insertion and oligomerization (Bellot et al., 2006; Etxebarria et al., 2008; Ott et al., 2007) . Several findings also suggest that components of the mitochondrial fission machinery, including the large GTPase of the dynamin superfamily Drp1 (Heymann and Hinshaw, 2009 ), may play a role in MOMP and cytochrome c release (Youle and Strasser, 2008) .
We previously reported that although tBid appears to be sufficient to trigger Bax oligomerization in synthetic liposomes (Kuwana et al., 2002; Lovell et al., 2008; Lucken-Ardjomande et al., 2008; Terrones et al., 2004) , additional proteins are required to induce efficient Bax oligomerization in the MOM (Roucou et al., 2002) . We searched for these proteins using a minimal cell-free assay and identified Drp1 as a protein capable of stimulating oligomerization of Bax upon its insertion into liposomes. We provide strong evidence that Drp1 stimulates Bax oligomerization by promoting membrane remodeling.
RESULTS

Drp1 Stimulates tBid-Dependent Bax Oligomerization in Liposomes
Our previous work showed that a MOM-associated protein is required to induce efficient tBid-induced Bax oligomerization (Roucou et al., 2002) . To identify this protein, we took advantage of a recently described acellular assay to monitor Bax oligomerization, based on the observation that Bax oligomers are partially resistant to trypsin (Goping et al., 1998; Lucken-Ardjomande et al., 2008) . In line with our previous data, when incubated with tBid and liposomes containing phosphatidylcholine, phosphatidylethanolamine, and cardiolipin (PC/PE/CL liposomes), a fraction of Bax became resistant to trypsin proteolysis ( Figure 1A ). Addition of high salt-extracted liver mitochondrial proteins stimulated tBid-induced Bax oligomerization, confirming the presence of a Bax-activating factor (BAF) in this extract ( Figure 1A ). In addition, we found that cytosolic extracts from rat liver or brain, or HeLa cells, also stimulated Bax oligomerization ( Figures 1A and 1F ). Bax activation required the presence of a functional tBid BH3 domain and was prevented by Bcl-x L ( Figure 1A) . Proteolysis of the brain cytosolic extract with proteinase K abolished BAF activity. Thus, BAF(s) is/are protein(s) present in the cytosol or weakly attached to mitochondria. Because of its high BAF-specific activity, the brain cytosolic extract was selected for biochemical purification of BAF. Cation exchange and size exclusion chromatographies allowed enrichment of BAF-specific activity in high-molecular-weight fractions (P1-P3; Figure 1B ). However, purification to homogeneity was not achieved due to a loss of activity during additional purification steps. We therefore decided to identify by mass spectrometry and/or western blot analysis the proteins present in P1, which displayed the highest specific activity, and to test them individually in the Bax activation assay. Negative results were obtained with a number of different proteins (data not shown, see the list in the legend of Figure 1B) , until we identified and tested Drp1 ( Figure 1C ). Recombinant Drp1 was able to activate Bax in a dose-dependent manner ( Figures 1D and 1E) , only in the presence of tBid (data not shown). To test whether Drp1 was responsible for the BAF activity present in the cytosolic extracts, we compared the activity of cytosolic extracts from control HeLa cells (expressing shLuc) and from HeLa cells depleted of Drp1 by RNA interference (shDrp1) (Parone et al., 2006) . Drp1 depletion decreased the activity of the cytosol ( Figure 1F ), implicating it in Bax oligomerization. However, a residual activity was still present in the Drp1-depleted cytosol perhaps because of an incomplete removal of Drp1 or because of the existence of additional BAFs.
Cardiolipin Binding Is Essential for Drp1's Ability to Promote Bax Oligomerization tBid has been previously reported to preferentially bind mitochondrial contact sites, to display a strong affinity for the negatively charged phospholipid CL (Lutter et al., 2000 and Figure 2B ), and to promote Bax oligomerization in CL-containing membranes (Kuwana et al., 2002; Lucken-Ardjomande et al., 2008) . The concentration of CL at contact sites has been reported to represent around 25% of the phospholipid content (Ardail et al., 1990) . This corresponds to the CL composition of the liposomes used in our study. When the amount of CL was reduced to 10%, a significant effect of Drp1 on tBid-induced Bax oligomerization was also observed, although less important than the effect obtained with liposomes containing higher CL concentrations ( Figure 2A ). In addition we found that Drp1 had a stronger affinity for CL than for phosphatidylserine (PS), another negatively charged phospholipid ( Figure 2B ), whereas the integral membrane protein hFis1, used as a control, bound equally well to CL-or PS-containing liposomes ( Figure 2B ). As both tBid and Drp1 showed an affinity for CL, the question arose as to whether tBid could alter binding of Drp1 to liposomes or vice versa. Figure S1 (available online) shows that, under our experimental conditions, the binding of tBid and Drp1 was not significantly different whether the proteins were added alone or together, in the presence of Bax. Binding of Drp1 to CL could be mediated by electrostatic interactions between negative charges of the phospholipid and positively charged amino acids exposed at the surface of the protein. We therefore mutated a number of these amino acids, including R201, R247, K255, and K256 of the GTPase domain of Drp1 ( Figure S2A ). Mutation of these residues, except R247, did not alter binding to liposomes (data not shown). Arginine 247 is a residue that is exposed at the surface of Drp1 and is conserved between dynamins 1 and 2 and Drp1 of various species (Figures S2A and S2B) . Mutations of R247 to an alanine or a glutamic acid (Drp1 R247A/E) significantly impaired the ability of Drp1 to bind CL-containing liposomes ( Figure 2C ), without impairing the GTPase activity of the protein ( Figure 2D ). In addition, the mutant proteins proved to be less efficient in promoting Bax oligomerization ( Figure 2E ), indicating that the binding of Drp1 to CLcontaining liposomes is required for stimulating tBid-induced Bax oligomerization.
Drp1 Stimulates Bax Oligomerization Independently of Its GTPase Activity
Because Drp1 is a large GTPase of the dynamin family, we further tested whether its GTPase activity was necessary to promote tBid-induced Bax oligomerization. Key amino acids in the GTPase domain were mutated to produce GTPase-deficient mutants (Drp1 K38A, Drp1D1-38, and Drp1 T59A/G149A/ K216A) ( Figure 2D ). Interestingly, all of these mutants were still capable of stimulating Bax oligomerization ( Figure 2F ), indicating that the GTPase activity of Drp1 is dispensable for Bax oligomerization. Supporting this finding, the buffer used to assay BAF in vitro did not contain GTP. However, it contained ATP, the role of which was therefore tested. In the presence of cytosol or Drp1 and tBid, but without ATP, Bax oligomerization dropped to the level obtained in the presence of Bax and tBid alone ( Figure 2G , left blot), indicating that ATP was important for Drp1 to stimulate tBid-induced Bax oligomerization. Other nucleotides, including GTP, GTPgS, ADP, and AMP, could not substitute for ATP ( Figure 2G , right blot), unless used at supraphysiological concentrations (>5 mM; data not shown). In contrast, the nonhydrolyzable ATP analog AMPpNp was almost as efficient as ATP, indicating that hydrolysis of ATP was not required for Bax activation ( Figure 2G ). Accordingly, we excluded the possibility that Drp1 acted as an ATPase (data not shown).
ATP was not required for membrane binding of Drp1 ( Figure 2C ) but proved to have an impact on its quaternary structure in the presence of liposomes. In agreement with previous data, Drp1 was purified as a tetramer as assessed by size exclusion chromatography (Zhu et al., 2004) . In the presence of either ATP alone (data not shown) or Bax, tBid, and CL-containing liposomes ( Figure 2H ), Drp1 remained tetrameric. However, in the presence of ATP, tBid, Bax, and liposomes, it was eluted in large molecular weight (MW) fractions, suggesting that the protein formed larger oligomers. A similar elution profile was obtained in the absence of tBid and Bax (data not shown). Drp1 present in the large MW fractions migrated as both a monomer ($80 kDa) and a dimer ($160 kDa) on SDS-PAGE, suggesting incomplete disassembly by the SDS present in the buffer ( Figure 2H ). This dimer was also detected by SDS-PAGE and Coomassie staining upon incubation of 500 nM Drp1 with liposomes and ATP ( Figure 2I and see also Figure 2C ). Further studies are necessary to determine how ATP promotes formation of high-order Drp1 oligomers.
Drp1 Promotes Tethering and Hemifusion of Cardiolipin-Containing Membranes
Interestingly, in the presence of ATP, liposomes clustered in a Drp1 dose-dependent manner, as shown by visual observation ( Figure 3A) and by a characteristic rise in the turbidity of the liposome suspension (Nakatogawa et al., 2007) (Figure 3B ). These aggregates disappeared after the addition of proteinase K, indicating that Drp1 was responsible for membrane tethering ( Figure 3B ).
Liposome aggregation could simply represent membrane bridging but could also represent hemifusion (i.e., fusion of the outer leaflets of adjacent membranes, while inner leaflets remain intact) or complete fusion (i.e., the merger of both inner and outer leaflets) of apposed membranes. In order to test these possibilities, we used a lipid-mixing assay, which is based on fluorescence resonance energy transfer from 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4yl) (NBD-PE) to 1,2-dioleoyl-snglycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rho-PE) (Struck et al., 1981) . PC/PE/CL large unilamellar vesicles (LUVs) were prepared with or without addition of NBD-PE and Rho-PE. When the two dyes are present at an appropriate concentration in the same liposome, the fluorescence of NBD is quenched by rhodamine. Upon fusion of these LUVs with unlabeled LUVs, the distance between the two dyes increases, resulting in a dequenching of NBD fluorescence. When the two LUV populations were mixed in the presence of Drp1, NBD fluorescence increased in a timeand dose-dependent manner, indicating that lipid mixing had occurred ( Figures 4A-4C ). The level of NBD fluorescence induced by Drp1 was about 50% of that obtained upon addition of detergent, which provides the maximum level of fluorescence (100%). As expected, the extent of lipid mixing obtained with Drp1 R247A was significantly reduced compared to Drp1 wildtype (WT) (Figures 4B and 4C ). On the other hand, no increase in NBD fluorescence was measured with heat-denatured Drp1 or when Drp1 was incubated in the presence of labeled LUVs alone ( Figure 4B ). Finally, consistent with the preferential binding of Drp1 to CL, replacing this phospholipid with PS, maintaining (D) GTPase activity of Drp1 WT and Drp1 mutants (1 mM each). Values are means of three independent experiments ± standard deviation (SD). Drp1 GTPase mutants differed from WT with ***: p < 0.001. (E) Comparison of the effects of Drp1 WT, Drp1 R247A, and Drp1 R247E (1 mM each) on tBid-induced Bax oligomerization. PC/PE/CL liposomes were incubated in the presence of 10 nM tBid, 50 nM Bax, and the indicated proteins before trypsin digestion and Bax analysis. The blot is representative of three independent experiments. See also Figure S2 the net charge of the vesicles, completely abolished the ability of Drp1 to trigger an increase in NBD fluorescence ( Figure 4D ). Thus, CL is critical for Drp1-induced lipid mixing. A similar conclusion was reached when lipid mixing was monitored by fluorescence-activated cell sorting (FACS) analysis (Figures S3A and  S3B) . We then investigated whether Drp1-induced lipid mixing resulted from complete membrane fusion or membrane hemifusion. We prepared asymmetrically labeled liposomes by adding the membrane-impermeable reductant sodium dithionite to the liposome suspension to selectively quench the fluorescence of NBD in the outer leaflet. The validity of the assay was checked with calcium, which is known to trigger complete fusion (Ortiz et al., 1999) . In the presence of 10 mM CaCl 2 , a significant increase in NBD fluorescence was still measured upon incubation of dithionite-treated LUVs with unlabeled LUVs, indicating that fusion of the inner leaflets of apposed membranes, i.e., complete fusion of vesicles, had occurred ( Figure 4B ). In contrast to calcium, under these conditions, Drp1 WT or Drp1 R247A had a small impact on NBD fluorescence, indicating that Drp1 mainly triggers fusion of the outer leaflet with minimal inner leaflet mixing (Figures 4A and 4B) . Consistent with these results, no fusion pore formation and content mixing occurred in the presence of Drp1. This result was established using the content-mixing fusion assay where liposomes filled with 8-aminonaphthalene-1,3,6-trisulfonic acid (ANTS) are mixed with liposomes filled with p-xylylenebis(pyridinium bromide) (DPX) (Ellens et al., 1985) . Vesicle fusion results in quenching of ANTS fluorescence. As a positive control, we used phospholipase C (PLC) from Bacillus cereus that had previously been reported to induce membrane fusion (Basanez et al., 1996) (Figure 4E ). In contrast to PLC, neither Drp1 WT nor Drp1 R247A induced aqueous content mixing, indicating that Drp1 does not trigger lipid pore formation and complete membrane fusion ( Figure 4E ).
According to the widely accepted stalk-pore fusion model (Chernomordik and Kozlov, 2008) , hemifusion is thought to start with the formation of a stalk, a local connection between the contacting monolayers of two membranes. The stalk then extends connecting the facing monolayers (hemifusion) before pore formation (fusion) occurs. The model predicts that addition of inverted cone-shaped lipids (i.e., positive curvature-inducing lipids) such as lyso-phosphatidylcholine (LPC) or lyso-phosphatidylethanolamine (LPE) to contacting membrane leaflets should prevent formation of hemifused intermediates (Chernomordik et al., 1995) , whereas cone-shaped lipids such as oleic acid (OA), which induce negative curvatures, should promote formation of hemifusion intermediates. Therefore, to confirm that Drp1 induced lipid mixing through formation of hemifusion intermediates, we added sublytic concentrations of LPC or LPE (Chernomordik et al., 1993) or OA to the vesicles ( Figure 4F ; see also Figure S3C ). Addition of LPC or, to a lesser degree, LPE that possesses a less positive intrinsic curvature than LPC significantly decreased total lipid mixing induced by Drp1 in a dosedependent manner. On the other hand, addition of OA slightly promoted Drp1-induced lipid mixing. When OA and LPC were added together, OA was able to counteract the inhibitory effect of LPC on lipid mixing. These data strongly argue that Drp1-induced lipid mixing is mediated by formation of membrane hemifusion intermediates.
Membrane Hemifusion Is Sufficient to Stimulate tBid-Induced Bax Oligomerization
Whereas LPC significantly reduced membrane hemifusion induced by Drp1, it also blocked the effect of Drp1 on Bax oligomerization ( Figure 4G ), suggesting that the capacity of Drp1 to facilitate tBid-induced Bax oligomerization is related to its capacity to promote membrane hemifusion. . Mean values ± SEM are shown for three independent experiments. PC and PC/PE/PS differed from PC/PE/CL with ***p < 0.001. (E) Comparison of the degree of aqueous content mixing elicited by Drp1 WT, Drp1 R247A, heat-denatured Drp1 WT (Heated Drp1 WT), and 0.1 nM Phospholipase C from Bacillus cereus (PLC). Content mixing was monitored by ANTS/DPX aqueous content mixing assay; 100% of content mixing was determined using LUVs containing both 12.5 mM ANTS and 45 mM DPX. Drp1 WT was incubated with ANTS containing LUVs as a control (Cont.) . Mean values ± SEM are shown for three independent experiments. Drp1 WT, Drp1 R247A, and heated Drp1 WT differed from PLC with ***p < 0.001. (F) Total lipid mixing induced by 158 nM Drp1WT in PC/PE/CL vesicles upon external addition of indicated concentrations of LPC, LPE, and OA. Mean values ± SEM are shown for three to seven independent experiments. Each LPC, LPE, and OA concentration differed from 0% with **p < 0.01, ***p < 0.001, or was not significantly different (ns). (G) PC/PE/CL liposomes containing 9 or 18 mol% LPC were used in in vitro Bax oligomerization assays. Drp1 was used at 1 mM. Blot shows duplicates and is representative of three independent experiments. (H) PC/PE/CL liposomes were incubated with tBid and Bax and increasing concentrations of cytochrome c at pH 6 before assaying Bax oligomerization. The blot is representative of three independent experiments.
Cytochrome c at pH 6 has previously been reported to stimulate membrane hemifusion (Kawai et al., 2005) . To demonstrate further the role of membrane hemifusion as the mechanism mediating the effect of Drp1 on tBid-induced Bax oligomerization, we tested whether hemifusion triggered by cytochrome c at pH 6 ( Figure S3D ) would also promote Bax oligomerization. We found that tBid-induced Bax oligomerization was enhanced by increasing concentrations of cytochrome c at pH 6 ( Figure 4H ), indicating that rather than Drp1 per se, it is the membrane hemifusion process that is directly responsible for potentiating tBid-induced Bax oligomerization.
Overexpression of Drp1 R247A or Drp1 R247E Delays Apoptosis We tested the physiological relevance of part of our findings in cellulo. We first analyzed the migration pattern of Drp1 from HeLa cells undergoing actinomycin D (ActD)-induced apoptosis by SDS-PAGE. In agreement with previous data (Breckenridge et al., 2003; Frank et al., 2001; Wasiak et al., 2007) , we observed that Drp1 was recruited to mitochondria during apoptosis ( Figure 5A ). Moreover, consistent with the data obtained with liposomes, we found that a proportion of Drp1 was detected as an $160 kDa band on SDS-PAGE, suggesting that Drp1 oligomerizes during apoptosis. We then expressed Drp1 R247A/E mutants in HeLa cells and tested their impact on mitochondrial morphology, Bax oligomerization, and cytochrome c release during apoptosis ( Figures 5B-5D and Figures 6A-6E ). Drp1 R247 A/E was found to coimmunoprecipitate with Drp1 WT, indicating that they likely formed heterooligomers ( Figure S4 ). Importantly, in 80% of cells expressing mutant Drp1 R247E, mitochondria formed very elongated tubules, which showed a number of vesicular dilatations (Figures 5B-5D ). These morphological alterations of mitochondria suggest that, despite a normal GTPase activity, Drp1 R247A/E has an impaired fission activity and exerts a dominant-negative effect over endogenous Drp1. Taken together with the weaker binding of Drp1 R247A to CL-containing liposomes, these findings suggest that CL could play a role in the mitochondrial recruitment and/or activity of Drp1, in a manner similar to what has been previously shown for the assembly of the dynamin-related protein Mgm1 in the inner mitochondrial membrane (DeVay et al., 2009) .
Bax oligomerization, monitored by the trypsin digestion assay ( Figures 6B and 6C) , by size exclusion chromatography ( Figure 6E ), or by crosslinking ( Figure S5 ), and MOMP, analyzed through the release of cytochrome c ( Figure 6D ), were significantly decreased in both Drp1 R247A/E and Bcl-2 expressing cells compared to cells transfected with an empty vector or to cells overexpressing Drp1 WT. Thus, expression of Drp1 R247A/E significantly decreased Bax oligomerization and MOMP in vivo. As a consequence, cells expressing the Drp1 mutants were more resistant to apoptosis than cells expressing equivalent amounts of Drp1 WT or than cells transfected with an empty plasmid when exposed to 3 mM ActD or UV irradiation ( Figures 7A and 7B ). Although the protection was significant at 6 hr after exposure to the stress stimulus, no protection was observed after 24 hr (data not shown), consistent with previously published results (Parone et al., 2006; Sheridan et al., 2008; Estaquier and Arnoult, 2007) . This indicates that other mechanisms can substitute for Drp1 to trigger Bax oligomerization.
DISCUSSION
Inhibition of Drp1 has previously been reported to delay cytochrome c release and apoptosis in vitro (Brooks et al., 2007; Frank et al., 2001; Germain et al., 2005; Ishihara et al., 2009; Lee et al., 2004; Cassidy-Stone et al., 2008) . Moreover, Drp1 null mouse embryos fail to undergo developmentally regulated apoptosis during neural tube formation in vivo (Wakabayashi et al., 2009) . Our results now explain that Drp1 participates in apoptosis by stimulating Bax oligomerization, thereby enhancing MOMP. By promoting Bax oligomerization and massive cytochrome c efflux, Drp1 could ensure that mitochondrial function is irreversibly altered during apoptosis, and that a sufficient amount of cytochrome c is released to activate APAF1. This would prevent cells from recovering after MOMP, a scenario that has been shown in cells expressing low caspase activity and high levels of GAPDH (Colell et al., 2007) . Drp1 may therefore correspond to the previously described macromolecular cytosolic factor termed PEF (permeability enhancing factor), which was defined as a proteinaceous macromolecule able to enhance MOMP by tBid and Bax (Kluck et al., 1999) .
Furthermore, we report that, in vitro, Drp1 promotes Bax oligomerization by triggering membrane tethering and hemifusion, independently of its GTPase activity. We provide evidence that rather than a direct interaction between Bax and Drp1, which we have not been able to detect (data not shown), formation of a Drp1-induced membrane hemifusion intermediate promotes tBid-induced Bax oligomerization. This membrane structure promoted by Drp1 in a reconstituted system may recapitulate the membrane remodeling that occurs at mitochondrial fission sites in cells undergoing apoptosis. Indeed, analogous to membrane fusion, membrane fission also proceeds via a pathway of intermediate structures. It has been shown that at membrane constriction sites, dynamins would pinch the membrane and bring into contact the inner leaflets of the membrane, allowing the formation of what has been called a hemifission intermediate (Kozlovsky and Kozlov, 2003) . Thus, during mitochondrial fission, Drp1 could constrict the MOM and trigger the formation of a hemifission intermediate at fission sites (see Figure 7C for a model). The occurrence of this mitochondrial membrane remodeling during apoptosis may provide the appropriate membrane curvature, lipid composition, and/or lateral pressure profile that are considered to be important for integral membrane protein oligomerization (Basañ ez et al., 2002; Lucken-Ardjomande et al., 2008; van den Brink-van der Laan et al., 2004) and may explain the preferential localization of Bax at mitochondrial fission sites in apoptotic cells (Karbowski et al., 2002) .
Our data also suggest that any mechanism that would lead to formation of membrane hemifusion intermediates during apoptosis may promote Bax oligomerization. Indeed, in the liposome assay, cytochrome c, which is able to trigger membrane hemifusion at pH 6, triggered tBid-induced Bax oligomerization as well as Drp1. Privileged sites where such a membrane remodeling could occur are contact sites between the inner and outer mitochondrial membranes, which are higly enriched in CL (Ardail et al., 1990) . In addition to stimulating Bax oligomerization, formation of hemifusion/hemifission intermediates could modify elasticity of the membrane through changes in lipid composition or structure and possibly the size of pores formed by the Bax oligomers. On the other hand, formation of the Bax (A) Mitochondrial and cytosolic extracts were prepared from HeLa cells cultured in the absence (time 0) or in the presence of ActD (3 mM) for 2, 4, and 6 hr. Cell extracts were separated by SDS-PAGE in the absence of DTT and analyzed for Drp1 by western blotting. Hsp90 and mHsp70 were used as loading controls for cytosolic and mitochondrial extracts, respectively. The blots are representative of four independent experiments. (B-D) HeLa cells were transfected with an empty DNA vector (pCI) or with plasmids encoding Drp1 WT or Drp1 R247E together with a mitochondria-targeted YFP. Forty-eight hours later, Drp1 expression levels were quantified in total cell extracts by western blot using an antibody to Drp1. Actin was used as a loading control. In parallel, mitochondrial morphology was analyzed by fluorescence microscopy. (B) Immunoblot shows that cells transfected with plasmids encoding Drp1 WT or Drp1 R247E expressed equivalent amounts of Drp1 WT and Drp1 R247E proteins. Actin was used as a loading control. See also Figure S4 . (C) Morphology of mitochondria in HeLa cells observed by fluorescence microscopy. White arrow denotes the presence of vesicular dilatations whereas arrowhead denotes highly elongated mitochondria. Bar is 5 mm. (D) Quantification of mitochondrial morphology. Mitochondria were divided into three classes: small tubular, which corresponds to cells mainly filled with small filaments of $2 mm or less; fragmented that corresponds to punctiform mitochondria; highly elongated, which corresponds to cells mainly filled with mitochondria >5 mm. Mean values ± SEM are shown for three independent experiments. (Figure 7 ), HeLa cells were transfected with an empty vector (pCI) or with plasmids encoding Bcl-2, Drp1 WT, or Drp1 R247A/E. The efficacy of transfection varied between 60% and 80%. Drp1 WT and Drp1 R247A/E were overexpressed at equivalent levels as shown by the immunoblot perfomed with an antibody to Drp1. Actin was used as a loading control. (B and C) Analysis of Bax insertion in the outer mitochondrial membrane by alkali treatment and Bax oligomerization by the trypsin digestion assay. HeLa cells were transfected as indicated in (A). Seventy-two hours after transfection, apoptosis was induced with 3 mM ActD (+ ActD). Four hours later, mitochondria were isolated and analyzed for Bax insertion by alkali treatment (inserted Bax) or Bax oligomerization by trypsin digestion (Tr-Bax). Tr-Bax was also analyzed in untreated HeLa cells (À ActD). Prohibitin was used as a mitochondrial loading control. Note that although Bax insertion was similar in cells transfected with pCI, Drp1 WT, or Drp1 R247A/E vectors, Tr-Bax levels were significantly lower in cells expressing Drp1 R247A/E or Bcl-2 as shown in (C), which is a compilation of results from four different experiments performed for pCI, Bcl-2, Drp1 R247A, and Drp1 R247E. Results represent a quantification of the immunoblots for trypsin-resistant Bax. Mean values ± SEM are shown for six independent experiments with *p < 0.05, **p < 0.01. oligomers could increase membrane tension and stretching, compromising the tightness of the membrane hemifusion/hemifission path and therefore inducing leakage of contents. Thus, hemifusion/hemifission intermediates could be thought of as an Achilles' heel targeted by Bax to damage the outer mitochondrial membrane and trigger cytochrome c release.
(D) HeLa cells were transfected as indicated in (A). Seventy-two hours later cells were treated with ActD for 4 hr in the presence of 100 mM z-VAD to avoid their detachment from the culture dish and immunostained for cytochrome c. Cells were analyzed by fluorescence microscopy and the number of cells with diffused cytochrome c staining was counted. Histograms display the means of three independent experiments ± SEM; ***p < 0.001. (E) Analysis of Bax oligomerization by size-exclusion chromatography. HeLa cells were transfected as indicated in (A). Seventy-two hours after transfection, cells were treated with 3 mM ActD to induce apoptosis. Six hours later mitochondria were isolated from cells undergoing apoptosis and from pCI transfected cells that were not exposed to ActD, as a control. Proteins were extracted from membranes with 2% CHAPS in 200 mM NaCl and fractionated by size-exclusion chromatography. Proteins in the eluted fractions were precipitated with tricholoroacetic acid and separated by SDS-PAGE before Bax immunoblotting (Right panel). One nanogram recombinant Bax was loaded on every blot (labeled with an asterisk) to control that every blot was exposed similarly to X-ray film during the chemiluminescence detection of proteins, allowing direct comparison of all immunoblots. In addition, Bcl-x L and Tom 20 were used as loading controls. The left panel shows levels of Bax that were associated with mitochondria before extraction. Results confirm those shown in (B, lower panel). Drp1 and mHsp70 (used as a loading control) were also blotted. See also Figure S5 . We speculate that contact sites between the inner and outer membranes, which are enriched in CL, could also be privileged sites for the formation of hemifusion intermediates, independently of Drp1. Contact sites could therefore represent additional sites in which Bax oligomerization would occur.
EXPERIMENTAL PROCEDURES Liposome Preparation
In most experiments, liposomes were prepared as described by LuckenArdjomande et al. (2008) . For lipid mixing assays, lipid mixtures at the indicated ratios were codissolved in chloroform/methanol (2:1). Organic solvents were removed by evaporation under nitrogen stream followed by incubation under vacuum for 2 hr. Dried lipid films were resuspended in the required buffers. LUVs were formed using 10 freeze/thaw cycles and two polycarbonate membranes of 0.2 mm pore size for extrusion (Nucleopore, San Diego, CA, USA). Unless otherwise stated, liposome composition was PC/PE/CL (54:20:26, mol/mol). Egg yolk PC, bovine heart CL, bovine brain PE, and bovine brain LPC were from Sigma or Avanti.
Lipid Mixing and Aqueous Content Mixing Assays in Large Unilamellar Vesicles
The resonance energy transfer assay of Struck et al. (1981) was used to monitor membrane lipid mixing. Briefly PC/PE/CL (54:20:26) LUVs containing 2 mol% of NBD-PE and 2 mol% Rh-PE were mixed with 9-fold excess of unlabeled LUVs. NBD-PE emission was monitored at 530 nm with the excitation wavelength set at 465 nm (slits, 4 nm). A 515 nm cut-off filter was placed between the sample and the emission monochromator to avoid scattering interference. Inner monolayer lipid mixing was measured using asymmetrically labeled membrane vesicles produced by the quenching of the outer leaflet NBD-PE fluorescence upon addition of sodium dithionite. Dithionite was removed by gel filtration in Sephadex G-25, using 125 mM KCl as elution buffer. Content mixing was monitored by the ANTS/DPX assay performed by Ellens et al. (1985) . LUVs containing either (1) 25 mM ANTS, 40 mM NaCl, and 10 mM HEPES, (2) 90 mM DPX and 10 mM HEPES, or (3) 12.5 mM ANTS, 45 mM DPX, 20 mM NaCl, and 10 mM HEPES were obtained by separating the nonencapsulated material by gel filtration on a Sephadex G-25 column eluted with 10 mM HEPES, 100 mM NaCl (pH 7.4). Osmolarity of all buffers was adjusted to 200 mOsm. ANTS emission was monitored at 530 nm with the excitation wavelength set at 360 nm (slits, 4 nm). A 470 nm cut-off filter was placed between the sample and the emission monochromator to avoid scattering interference. The 0% vesicle content mixing was set by using a 1:1 mixture of ANTS and DPX liposomes. The 100% mixing of contents corresponded to the fluorescence of the vesicles containing coencapsulated ANTS and DPX.
Unless otherwise stated, LUVs (60 mM lipid) were incubated with 1 mM ATP and 1 mM MgCl 2 prior to treatment with Drp1. Experiments were performed in an SLM-8100 Aminco-Bowman luminescence spectrometer (Spectronic Instruments, Rochester, NY, USA) in a thermostated 1 cm path length cuvette with constant stirring at 37 C.
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